In our study, we performed CRISPR knockdown screening to determine that MIEF2 deletion was a key driver of OXL resistance in CRC and elucidated that MIEF2 loss reduced mitochondrial cytochrome C release, thereby inhibiting endogenous apoptosis, and eventually leading to OXL resistance in CRC. The gene discussed is MIEF2; the disease is colorectal carcinoma.